Endometrial cancerCost-effectivenessDostarlimabTrastuzumabHER2Mismatch repair (MMR)
trainee volume, fellowship training, gynecologic oncology training, surgical education, cancer trends
nab-paclitaxel, advanced primary or recurrent endometrial cancer, feasibility, immune checkpoint inhibitors
endometrial cancer, Next-generation sequencing, Molecular profiling, Cost-effectiveness
endometrial cancer, postmenopausal bleeding, transvaginal ultrasound, endometrial thickness, endometrial visualization